🇺🇸 FDA
Patent

US 9890379

Treatment of genetic disorders associated with DNA repeat instability

granted A61KA61K48/00A61P

Quick answer

US patent 9890379 (Treatment of genetic disorders associated with DNA repeat instability) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN TECHNOLOGIES B.V.
Grant date
Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K48/00, A61P, A61P21/00, A61P25/00